[
  {
    "protocolSection": {
      "identificationModule": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
        "nctId": "NCT02078076",
        "briefTitle": "IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie s\u00e9v\u00e8re"
=======
        "nctId": "NCT02436720",
        "briefTitle": "Upper Limb Assessment in Duchenne Muscular Dystrophy"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-03-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-02-24"
=======
          "date": "2013-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-05-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-07"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "name": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France"
=======
          "name": "Catholic University of the Sacred Heart"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "conditionsModule": {
        "conditions": [
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "Duchenne or Severe Becker Myopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
=======
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
        "nctId": "NCT02484560",
        "briefTitle": "Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-06-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-07-01"
=======
        "nctId": "NCT00873782",
        "briefTitle": "Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-04-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-03-09"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "name": "University of Gaziantep"
=======
          "name": "University of North Carolina, Chapel Hill"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "conditionsModule": {
        "conditions": [
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "Duchenne Muscular Dystrophy"
=======
          "Muscular Dystrophies",
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Limb-Girdle Muscular Dystrophy"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
        "nctId": "NCT05305976",
        "briefTitle": "Telerehabilitation in Duchenne Muscular Dystrophy"
=======
        "nctId": "NCT04626674",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "date": "2021-01-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-31"
=======
          "date": "2020-11-23"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-11-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-26"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "name": "Karadeniz Technical University"
=======
          "name": "Sarepta Therapeutics, Inc."
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
<<<<<<< HEAD:data/duchenne_studies_sample.json
          "NA"
=======
          "PHASE1"
>>>>>>> d768e195b71b5fb2c3a6ebad5b047bcbd980adc6:duchenne_studies_sample.json
        ]
      }
    }
  }
]